University of East Anglia Featured PhD Programmes
Aberdeen University Featured PhD Programmes
Lancaster University Featured PhD Programmes
"drugs" AND "design"×
10 miles

Pharmacy / Pharmaceutics (drugs design) PhD Projects, Programs & Scholarships

We have 14 Pharmacy / Pharmaceutics (drugs design) PhD Projects, Programs & Scholarships

  • "drugs" AND "design" ×
  • Pharmacy / Pharmaceutics×
  • clear all
Order by 
Showing 1 to 14 of 14
  Formulation of poorly-soluble drugs
  Prof V Khutoryanskiy
Applications accepted all year round

Funding Type

PhD Type

Poorly water-soluble drugs is an important class of pharmaceutical compounds that are finding numerous applications for the therapy of different pathological conditions.
  The molecular mechanisms underpinning individual variation in platelet function and their effect on the progression and treatment of cardiovascular disease.
  Dr CI Jones
Applications accepted all year round

Funding Type

PhD Type

Platelets are small blood cells that play a vital role in the chronic and acute progression of Cardiovascular Disease (CVD). Platelets respond to a range of agonists, which are released when blood vessels are damaged, by aggregating together to form thrombi.
  (iCASE Award) Towards Particle Design of Pharmaceutical Crystals
  Dr A Cruz-Cabeza
Application Deadline: 30 June 2020

Funding Type

PhD Type

This project is being pursued in collaboration with AstraZeneca and the successful applicant will be part of a larger research group supervised by Dr.
  Carbon Nanotubes Mediated Drug Delivery in 3D cancer models
  Dr H Ali-Boucetta
Applications accepted all year round

Funding Type

PhD Type

Current treatment with anticancer drugs suffers from the drawbacks of systemic toxicity, drug resistance and limited cellular entry.
  Fundamentals of the Chromatographic Separation Processes of Peptide Therapeutics
  Prof D Williams
Applications accepted all year round

Funding Type

PhD Type

Imperial College are inviting applications for a PhD position to join an exciting new Engineering and Physical Sciences Research Council (EPSRC) Prosperity Partnership between Imperial, UCL and Eli Lilly on Transforming synthetic drug manufacturing.
  Microfluidic Synthesis of Nanomedicines for the Delivery of Biologic Drugs
  Dr D Lamprou
Applications accepted all year round

Funding Type

PhD Type

Progress in drug design has led to the development of new molecules. However, the limited ability to selectively deliver these molecules at well-defined dosing regimens remains a significant challenge.
  Toxicological Assessment of Carbon Based Nanomaterials
  Dr H Ali-Boucetta
Applications accepted all year round

Funding Type

PhD Type

The use of sophisticated delivery systems that allow the delivery and targeting of anti-cancer drugs into tumour tissue is an ever expanding area of research.
  Toxicological Assessment of Nanomaterials towards the development of a Nanotoxocicology Framework
  Dr H Ali-Boucetta
Applications accepted all year round

Funding Type

PhD Type

The use of sophisticated delivery systems that allow the delivery and targeting of anti-cancer drugs into tumour tissue is an ever expanding area of research.
  MSc by Research Programme: Development of novel therapeutics against parasitic disease
  Prof M Field
Application Deadline: 16 July 2020

Funding Type

PhD Type

This course allows you to work alongside our world renowned experts from the School of Life Sciences and gain a ’real research’ experience.
  Computer Simulations of G protein-coupled Receptors
  Dr I Tikhonova
Applications accepted all year round

Funding Type

PhD Type

Many physiological processes are controlled through the activation of G protein-coupled receptors (GPCRs) by regulatory peptides, making peptide GPCRs particularly useful targets for major human diseases such as diabetes and CNS diseases.
  Novel drug delivery systems for Schizophrenia treatment
  Dr E Larraneta
Applications accepted all year round

Funding Type

PhD Type

This PhD project aims to develop, characterise and test a new type of implantable device to provide sustained antipsychotic drug delivery for schizophrenia treatment.
  To develop an allosteric inhibitor of HDAC6 inhibition in cancer
  Dr F Furlong, Dr I Tikhonova
Applications accepted all year round

Funding Type

PhD Type

The HDAC6 protein is upregulated in cancer and associated with increased proliferation and metastasis. Several HDAC6 inhibitors have been developed and are in clinical trials.
  Pharmacoengineering of advanced RNA-nanomedicines to treat cystic fibrosis (CF)
  Prof S Cryan, Prof A Heise, Prof C Greene
Applications accepted all year round

Funding Type

PhD Type

Cystic fibrosis (CF) is an inherited disorder caused by a mutation in a single gene responsible for the production of a protein called the cystic fibrosis transmembrane conductance regulator (CFTR).
  Development of pulmonary dosage forms for improved antibacterial activity
  Dr H Al-Obaidi
Applications accepted all year round

Funding Type

PhD Type

"Conventional formulations for drug delivery to the lungs are limited to less than a few milligrams as a fine particle fraction.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.